Records · procedure · next step
Medical-appliance reimbursement listing: file map
A reimbursement-listing file identifies the means, appliance or associated service, category, indications and supporting evidence. France separates LPPR listing, CNEDiMTS opinion and CEPS tariff documents. Swiss LiMA/MiGeL listing has its own federal-office and commission process, limitations and maximum remuneration rules. Marketability does not establish listing or a patient payment right. The register organises actual documents without rating clinical benefit or predicting approval.
General information and document preparation. The facts, actual procedural acts and applicable versions must be checked.
Julie’s legal research currently covers French law. The Swiss sections prepare documents; they do not establish Swiss-law product capability.
Julie by AlphaDeep
Which jurisdiction and listing documents are involved? Julie’s legal research currently concerns French law.
3 free questions at signup. Avoid names and sensitive information.
France: what category and listing route are identified?
L.165-1 distinguishes covered products/services and generic description versus brand/commercial-name listing. A product’s commercial name does not select the route.
France: where does the manufacturer/distributor submit?
R.165-7 specifies the health/social-security ministers with simultaneous CNEDiMTS copy, and a separate CEPS copy with tariff information.
Prepare the records
Julie’s legal research currently covers French law. The Swiss sections prepare documents; they do not establish Swiss-law product capability.
Synthetic example
Product, listing-evidence and authority-stage matrix
- Product
- Synthetic DM1; masked supplier F1
- Category
- Actual listing group/route unknown
- Indication
- I1; no clinical assessment
- Evidence
- E1/E2 references only
- Filing
- Actual recipients and dispatch not established
- Opinion
- No commission opinion/decision supplied
- Tariff
- Proposed P1; no agreed price or reimbursement
This record organises supplied documents and values; it certifies no entitlement, permission or safety.
France: how is evidence tied to expected service?
R.165-2 distinguishes indications, populations, product interest/risks/place and public-health interest. No clinical sufficiency rating is generated here.
France: which opinion stages remain separate?
R.165-12 covers communicated opinion, observations/hearing and final opinion. Preserve actual receipt and versions without treating a draft as approval.
Switzerland: does every provider-used product follow the list?
OPAS 20 separates its specified means/appliance categories from other provider-used items remunerated through the treatment tariff.
Switzerland: where does a new-listing request go?
Article 21 directs it to the federal health office, which examines and presents it to the federal analyses/means/appliances commission. Submission is not admission.
Switzerland: what limits may an entry contain?
Article 22 permits limits such as quantity, duration, indication or age;23 separately requires lawful marketability under relevant federal/cantonal rules.
Switzerland: is a maximum the product’s accepted price?
Article 24 distinguishes applicable maximum remuneration, sale/rental costs and specified conventions. A quoted price is not an individual reimbursement conclusion.
Frequently asked questions
France: what category and listing route are identified?
L.165-1 distinguishes covered products/services and generic description versus brand/commercial-name listing. A product’s commercial name does not select the route.
France: how is evidence tied to expected service?
R.165-2 distinguishes indications, populations, product interest/risks/place and public-health interest. No clinical sufficiency rating is generated here.
Switzerland: where does a new-listing request go?
Article 21 directs it to the federal health office, which examines and presents it to the federal analyses/means/appliances commission. Submission is not admission.
Switzerland: is a maximum the product’s accepted price?
Article 24 distinguishes applicable maximum remuneration, sale/rental costs and specified conventions. A quoted price is not an individual reimbursement conclusion.